Preclinical Imaging In Vivo Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Preclinical Imaging In Vivo Market to 2027 - Global Analysis and Forecasts By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems and Others), Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, MRI Contrast Agents, and CT Contrast Agents) and Geography

Report Code: TIPMD00002567 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally.

The market of preclinical imaging in vivo is anticipated to grow with a significant rate in the coming years, owing to factors such as technological advancements, and growth in prevalence of chronic disease such as cancer, cardiovascular, rheumatoid arthritis, and neurological disorders driving the preclinical imaging market globally. Due to rise in number of population, increase in opportunity for clinical and preclinical studies in low cost, and government support for research and development activities Europe is expected to offer growth opportunities for the players operating in the market.

The "Global Preclinical Imaging in Vivo Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global Preclinical Imaging in Vivo market with detailed market segmentation by modality and reagents. The global Preclinical Imaging in Vivo market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global preclinical imaging in vivo market is segmented on the basis of modality and reagents. The modality segment includes, optical imaging systems, nuclear imaging systems, micro-MRI systems, and others. The segment of optical imaging systems is further classified into bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-ray/optical + CT. The segment of nuclear imaging systems is further classified into micro-PET systems, micro-SPECT systems, trimodality (SPECT/PET/CT) systems. Based on reagents, the market is segmented as, preclinical optical imaging reagents, preclinical nuclear imaging reagents, MRI contrast agents, and CT contrast agents. The segment of preclinical optical imaging reagents is further classified into bioluminescent reagents, fluorescent imaging reagents. The segment of preclinical nuclear imaging reagents is further classified into, preclinical PET tracers and preclinical SPECT probes.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Preclinical Imaging in Vivo market based on modality, reagents. It also provides market size and forecast till 2027 for overall Preclinical Imaging in Vivo market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

Geographically, North America dominates the preclinical imaging market due to rapid adoption of several type of modalities by end-user, technological advancement, growth in prevalence of chronic diseases such as cancer, cardiovascular disease, and others. Europe is the second largest market for preclinical imaging due to growing health care awareness among people and increasing number of research and development activities. Asia Pacific is expected to grow at a higher rate due to rise in number of population, increase in opportunity for clinical and preclinical studies in low cost, and government support for research and development activities.

The preclinical imaging in vivo marketreport analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The preclinical imaging in vivo marketreport also includes the profiles of key preclinical imaging in vivo companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market PerkinElmer, Inc., Bruker, FUJIFILM, Mediso Ltd., MILabs B.V., MR Solutions, LI-COR inc, Aspect Imaging , TriFoil Imaging, and Miltenyi Biotech among others.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. PRECLINICAL IMAGING IN VIVO MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Preclinical Imaging In Vivo Market - By Modality
3.2.2. Preclinical Imaging In Vivo Market - By Reagent
3.2.3. Preclinical Imaging In Vivo Market - By Region
3.2.3.1. By Country

4. PRECLINICAL IMAGING IN VIVO MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. PRECLINICAL IMAGING IN VIVO MARKET - GLOBAL ANALYSIS
5.1. GLOBAL PRECLINICAL IMAGING IN VIVO MARKET OVERVIEW
5.2. GLOBAL PRECLINICAL IMAGING IN VIVO MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2027 - BY MODALITY
6.1. OVERVIEW
6.2. MODALITY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. OPTICAL IMAGING SYSTEMS MARKET
6.3.1. Overview
6.3.2. Optical Imaging Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Bioluminescence/Fluorescence Imaging Systems Market
6.3.3.1. Overview
6.3.3.2. Bioluminescence/Fluorescence Imaging Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Standalone Fluorescence Imaging Systems Market
6.3.4.1. Overview
6.3.4.2. Standalone Fluorescence Imaging Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Optical + X-Ray/Optical + CT Market
6.3.5.1. Overview
6.3.5.2. Optical + X-Ray/Optical + CT Market Revenue Forecasts and Analysis (US$ Mn)
6.4. NUCLEAR IMAGING SYSTEMS MARKET
6.4.1. Overview
6.4.2. Nuclear Imaging Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3. Micro-PET Systems Market
6.4.3.1. Overview
6.4.3.2. Micro-PET Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.4.4. Micro-SPECT Systems Market
6.4.4.1. Overview
6.4.4.2. Micro-SPECT Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.4.5. Trimodality (SPECT/PET/CT) Systems Market
6.4.5.1. Overview
6.4.5.2. Trimodality (SPECT/PET/CT) Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.5. MICRO-MRI SYSTEMS MARKET
6.5.1. Overview
6.5.2. Micro-MRI Systems Market Revenue Forecasts and Analysis (US$ Mn)
6.6. OTHERS MARKET
6.6.1. Overview
6.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

7. PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2027 - BY REAGENTS
7.1. OVERVIEW
7.2. REAGENTS MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. PRECLINICAL OPTICAL IMAGING REAGENTS MARKET
7.3.1. Overview
7.3.2. Preclinical Optical Imaging Reagents Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Bioluminescent Reagents Market
7.3.3.1. Overview
7.3.3.2. Bioluminescent Reagents Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4. Fluorescent Imaging Reagents Market
7.3.4.1. Overview
7.3.4.2. Fluorescent Imaging Reagents Market Revenue Forecasts and Analysis (US$ Mn)
7.4. PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET
7.4.1. Overview
7.4.2. Preclinical Nuclear Imaging Reagents Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Preclinical PET Tracers Market
7.4.3.1. Overview
7.4.3.2. Preclinical PET Tracers Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4. Preclinical SPECT Probes Market
7.4.4.1. Overview
7.4.4.2. Preclinical SPECT Probes Market Revenue Forecasts and Analysis (US$ Mn)
7.5. MRI CONTRAST AGENTS MARKET
7.5.1. Overview
7.5.2. MRI Contrast Agents Market Revenue Forecasts and Analysis (US$ Mn)
7.6. CT CONTRAST AGENTS MARKET
7.6.1. Overview
7.6.2. CT Contrast Agents Market Revenue Forecasts and Analysis (US$ Mn)
8. NORTH AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA PRECLINICAL IMAGING IN VIVO MARKET OVERVIEW
8.2. NORTH AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY MODALITY (US$ MN)
8.3.1. North America Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.3.2. North America Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.4. NORTH AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY REAGENTS (US$ MN)
8.4.1. North America Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.4.2. North America Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.5. NORTH AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
8.6.1.1. US Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.1.2. US Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.2. US Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
8.6.2.1. US Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.2.2. US Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
8.7.1.1. Canada Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.1.2. Canada Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.2. Canada Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
8.7.2.1. Canada Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.2.2. Canada Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
8.8.1.1. Mexico Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.1.2. Mexico Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.2. Mexico Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
8.8.2.1. Mexico Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.2.2. Mexico Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)

9. EUROPE PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE PRECLINICAL IMAGING IN VIVO MARKET OVERVIEW
9.2. EUROPE PRECLINICAL IMAGING IN VIVO MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY MODALITY (US$ MN)
9.3.1. Europe Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.3.2. Europe Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. EUROPE PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY REAGENTS (US$ MN)
9.4.1. Europe Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4.2. Europe Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.5. EUROPE PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. UK MARKET OVERVIEW
9.6.1. UK Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
9.6.1.1. UK Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.1.2. UK Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.2. UK Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
9.6.2.1. UK Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.2.2. UK Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
9.7.1.1. Germany Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.1.2. Germany Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. Germany Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
9.7.2.1. Germany Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2.2. Germany Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8. FRANCE MARKET OVERVIEW
9.8.1. France Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
9.8.1.1. France Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.1.2. France Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. France Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
9.8.2.1. France Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2.2. France Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)

10. ASIA PACIFIC PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC PRECLINICAL IMAGING IN VIVO MARKET OVERVIEW
10.2. ASIA PACIFIC PRECLINICAL IMAGING IN VIVO MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY MODALITY (US$ MN)
10.3.1. Asia Pacific Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.3.2. Asia Pacific Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. ASIA PACIFIC PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY REAGENTS (US$ MN)
10.4.1. Asia Pacific Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4.2. Asia Pacific Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.5. ASIA PACIFIC PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. JAPAN MARKET OVERVIEW
10.6.1. Japan Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
10.6.1.1. Japan Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.1.2. Japan Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.2. Japan Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
10.6.2.1. Japan Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.2.2. Japan Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7. CHINA MARKET OVERVIEW
10.7.1. China Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
10.7.1.1. China Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.1.2. China Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2. China Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
10.7.2.1. China Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2.2. China Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8. INDIA MARKET OVERVIEW
10.8.1. India Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
10.8.1.1. India Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.1.2. India Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. India Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
10.8.2.1. India Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2.2. India Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) PRECLINICAL IMAGING IN VIVO MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) PRECLINICAL IMAGING IN VIVO MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY MODALITY (US$ MN)
11.3.1. Middle East and Africa (MEA) Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.3.2. Middle East and Africa (MEA) Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. MIDDLE EAST AND AFRICA (MEA) PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY REAGENTS (US$ MN)
11.4.1. Middle East and Africa (MEA) Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4.2. Middle East and Africa (MEA) Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.5. MIDDLE EAST AND AFRICA (MEA) PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. UAE MARKET OVERVIEW
11.6.1. UAE Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
11.6.1.1. UAE Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.1.2. UAE Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. UAE Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
11.6.2.1. UAE Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2.2. UAE Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
11.7.1.1. Saudi Arabia Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.1.2. Saudi Arabia Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.2. Saudi Arabia Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
11.7.2.1. Saudi Arabia Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.2.2. Saudi Arabia Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8. SOUTH AFRICA MARKET OVERVIEW
11.8.1. South Africa Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
11.8.1.1. South Africa Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.1.2. South Africa Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.2. South Africa Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
11.8.2.1. South Africa Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.2.2. South Africa Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12. SOUTH AND CENTRAL AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA PRECLINICAL IMAGING IN VIVO MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY MODALITY (US$ MN)
12.3.1. South and Central America Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.3.2. South and Central America Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4. SOUTH AND CENTRAL AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY REAGENTS (US$ MN)
12.4.1. South and Central America Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4.2. South and Central America Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.5. SOUTH AND CENTRAL AMERICA PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Modality (US$ Mn)
12.6.1.1. Brazil Optical Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.1.2. Brazil Nuclear Imaging Systems Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.2. Brazil Preclinical Imaging In Vivo Market Revenue Forecasts and Analysis - By Reagents (US$ Mn)
12.6.2.1. Brazil Preclinical Optical Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.2.2. Brazil Preclinical Nuclear Imaging Reagents Market Revenue and Forecasts Analysis - By Type (US$ Mn)


13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions
14. PRECLINICAL IMAGING IN VIVO MARKET, KEY COMPANY PROFILES
14.1. PERKINELMER, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BRUKER
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. FUJIFILM INDIA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. MEDISO LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. MILABS B.V
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MR SOLUTIONS
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. ASPECT IMAGING
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. LI-COR INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. TRIFOIL IMAGING
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. MILTENYI BIOTEC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. PerkinElmer, Inc.
2. Bruker
3. Fujifilm India
4. Mediso Ltd.
5. Milabs B.V.
6. MR Solutions
7. Aspect Imaging
8. Li-Cor, Inc
9. Trifoil Imaging
10. Miltenyi Biotec